Newsletter Subject

One year later, where's all the Adderall?

From

time.com

Email Address

TIME@newsletters.time.com

Sent On

Tue, Oct 17, 2023 08:52 PM

Email Preheader Text

Plus more health news | Email not displaying correctly? By Haley Weiss Health Reporter It?s not un

Plus more health news | Email not displaying correctly? [View it in your browser.]( [Health Matters]( [The mystery of the Adderall shortage only deepens]( By Haley Weiss Health Reporter It’s not unusual for a drug shortage to last more than a year, but there’s usually a pretty clear reason. The Adderall shortage, meanwhile—which hit the one-year mark last week—remains a mystery. The U.S. Food and Drug Administration (FDA) has shared little information with the millions of Americans who have struggled to access the common ADHD treatment. Experts who have spent their careers studying shortages are “baffled.” As it turns out, there might not be a single person who actually knows what’s causing the Adderall shortage. Lawmakers say that’s because the three parties that work together to get the medication bottled and sold aren’t required to communicate enough with one another—and nobody wants to accept the blame. Here’s who’s involved: - The U.S. Drug Enforcement Administration (DEA). Because amphetamine salts, which are the active ingredient in Adderall, are controlled substances, the agency sets an annual cap on how much manufacturers can use. Even though the DEA has to share this quota publicly, it doesn’t have to disclose any information about how the total is split among manufacturers. And by the way: 30% of last year’s quota never made it to the public. - The FDA. The FDA helps the DEA set its annual quota, and it also determines the regulations for how Adderall can be manufactured and sold. The agency has the power to enforce movement on shortages, but only to a point. Right now, the FDA has joined the DEA in blaming manufacturers for delays, citing the allotment that never made it to market. - Drug companies. Pharmaceutical companies are required to inform the FDA about medication shortages, but they don’t have to provide detailed information about the cause. Manufacturers have mainly blamed increased prescription rates for the shortage, but there’s really no way to know for sure what’s going on. [READ MORE]( Share This Story What Else to Read [If You’re Feeling Anxious, Try This 2,000-Year-Old, Neuroscience-Backed Hack]( By Julia Hotz Imagining the worst that can happen through dedicated 'worry time’ can help stop anxiety in its tracks. [Read More »]( [Why Rewatching Your Favorite TV Show Is Good for You]( By Anna Goldfarb Rewatching TV shows helps people unwind and provides a sense of comfort, research finds. [Read More »]( [The Daily Habits of Happiness Experts]( By Angela Haupt Stop trying to force that frown upside down. Instead, try the joy-building tips experts really use. [Read More »]( [Here’s Why You Always Feel Sicker at Night]( By Markham Heid You're not imagining it. (Originally published in 2019.) [Read More »]( [What Science Really Says About Grilled Meat and Cancer Risk]( By Markham Heid The research on is much less clear than many believe. (Originally published in 2019.) [Read More »]( ONE LAST READ [The history of Operation Warp Speed]( Operation Warp Speed, which gave the U.S. its first COVID-19 vaccines, is cited as one of the few success in the country’s pandemic response. In an excerpt appearing in Vanity Fair from The Big Fail: What the Pandemic Revealed About Who America Protects and Who It Leaves Behind, Joe Nocera and Bethany McLean describe how the urgency of a new infectious disease forced an unprecedented collaboration between the government and the pharmaceutical industry to produce vaccines in record time. [Read More »]( If you were forwarded this and want to sign up to receive it daily, [click here](. Today's newsletter was written by Haley Weiss and Alice Park, and edited by Angela Haupt. [Want more from TIME? Sign up for our other newsletters.]( [Subscribe to TIME]( TIME may receive compensation for some links to products and services in this email. Offers may be subject to change without notice. Connect with TIME via [Facebook]( | [Twitter]( | [Newsletters]( [UNSUBSCRIBE]( [PRIVACY POLICY]( [YOUR CALIFORNIA PRIVACY RIGHTS]( TIME Customer Service, P.O. Box 37508, Boone, IA 50037-0508 Questions? Contact health@time.com Copyright © 2023 TIME USA, LLC. All rights reserved.

Marketing emails from time.com

View More
Sent On

31/05/2024

Sent On

30/05/2024

Sent On

29/05/2024

Sent On

28/05/2024

Sent On

24/05/2024

Sent On

23/05/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.